Key facts
- This page summarizes Uri Geiger's Form 4 filing for STRATA Skin Sciences, Inc. (SSKN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jul 2024, 17:08.
Uri Geiger - 15 Jul 2024 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- SSKN
- Reported as of
- 15 Jul 2024
- Net transaction value
- +$723,999
- SEC form
- 4
- Accepted by SEC
- 17 Jul 2024, 17:08:57 UTC
- Prior SEC filing
- 11 Jun 2024
- Next SEC filing
- 09 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Uri Geiger
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Uri Geiger filed Form 4 for STRATA Skin Sciences, Inc. (SSKN) on 17 Jul 2024.
Change
- Previous filing in this sequence was filed on 11 Jun 2024.
- Current net transaction value: +$723,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SSKN
transaction
Common Stock
Purchase
- Transaction value
- $723,999
- Shares
- +230,573
- Change %
- +19%
- Price
- $3.14
- Shares after
- 1,441,835
- Date
- 15 Jul 2024
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares are held directly by Accelmed Partners, L.P. The reporting person is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Partners (GP), L.P., which is the general partner of Accelmed Partners, L.P. and as a result he may be deemed to beneficially own the shares of common stock held by Accelmed Partners, L.P. The reporting person is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares of common stock owned by Accelmed Partners, L.P. pursuant to a management agreement, and as a result the reporting person may be deemed to beneficially own the shares of the common stock held by Accelmed Partners, L.P. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein.